Anti-VEGF therapy improves outcomes in retinal diseases by targeting neovascularization and macular edema, crucial in conditions like AMD and diabetic retinopathy. Optical coherence tomography is ...

Moore’s widower, S. Robert Levine, MD, launched the nonprofit in his famous wife’s memory to advance research and accelerate ...

Please provide your email address to receive an email when new articles are posted on . Patients with inherited retinal diseases may present with seemingly routine conditions. Look for comorbid ...

Retinal diseases such as age-related macular degeneration (AMD) and diabetic retinopathy affect millions of people globally, often leading to vision loss with minimal straightforward treatment.

Congress finally reauthorized the Rare Pediatric Disease Priority Review Voucher program, after it expired in 2024. That ...

Gene therapy emerges as a transformative force in ophthalmology, offering renewed hope for patients with retinal diseases. This innovative approach targets both inherited and acquired conditions, ...

The 2003 annual meeting of the Association for Research in Vision and Ophthalmology (ARVO) was held in May in Fort Lauderdale, Florida. The retinal sessions were dominated by reports of new treatments ...

Neurotech Pharmaceuticals Inc., whose executive chairman is well-known Orange County executive Jim Mazzo, announced that it received FDA approval for its treatment of a type of macular telangiectasia ...

INDICATIONS EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...

SOL-1 Phase 3 superiority trial results remain masked to dateSOL-1 data expected to be presented at the 49th Macula Society Annual Meeting Ocular ...

A common infection may reach the eye, trigger inflammation, and worsen memory loss linked to Alzheimer’s disease.